stride study semaglutide in peripheral artery disease and diabetes by baseline disease severity and age: the trial 🎙️NEW #ADA2025 #LBCT Interview 💫Dr

The STEP UP trial's results suggest that higher doses of semaglutide could provide significant benefits for weight management, potentially challenging tirzepatide as a leading treatment

Costs vary by clinic location and depend on insurance coverage

Here are a few key things to be mindful of: Dosage: The higher your dosage, the more effective Semaglutide will be

This approval addresses a significant gap in the market: weekly shots such as Wegovy and Eli Lillys Zepbound have dominated the anti-obesity market to date

Our weight loss program in East Whittier, California employs weight loss experts who understand that each patient's body reacts differently to medications, and what works well for one person may not be suitable for another

They do not offer compounded GLP-1 medications